Dr. Kelli Dumm, MD

NPI: 1760461164
Total Payments
$3,102
2024 Payments
$564.34
Companies
35
Transactions
190
Medicare Patients
2,697
Medicare Billing
$236,038

Payment Breakdown by Category

Food & Beverage$3,057 (98.5%)
Education$45.45 (1.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,057 188 98.5%
Education $45.45 2 1.5%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $899.53 60 $0 (2024)
PFIZER INC. $293.47 15 $0 (2024)
ABBVIE INC. $269.17 13 $0 (2024)
Lilly USA, LLC $209.83 12 $0 (2024)
AstraZeneca Pharmaceuticals LP $129.47 10 $0 (2021)
GlaxoSmithKline, LLC. $120.99 8 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $100.30 6 $0 (2021)
Sumitomo Pharma America, Inc. $86.80 4 $0 (2024)
Janssen Pharmaceuticals, Inc $80.21 5 $0 (2021)
SANOFI-AVENTIS U.S. LLC $74.08 5 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $564.34 29 Novo Nordisk Inc ($209.64)
2023 $241.03 12 Novo Nordisk Inc ($70.81)
2022 $405.21 23 Novo Nordisk Inc ($183.78)
2021 $438.17 29 Novo Nordisk Inc ($172.82)
2020 $292.48 18 Novo Nordisk Inc ($76.00)
2019 $289.86 20 Novo Nordisk Inc ($53.69)
2018 $404.57 25 PFIZER INC. ($122.78)
2017 $466.70 34 Novo Nordisk Inc ($117.85)

All Payment Transactions

190 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
12/20/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $20.14 General
Category: UROLOGY
11/22/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $17.64 General
Category: PAIN
11/05/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $19.26 General
Category: Diabetes
11/02/2024 ABBVIE INC. SYNTHROID (Drug) Food and Beverage In-kind items and services $28.71 General
Category: IMMUNOLOGY
10/22/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $27.11 General
Category: UROLOGY
10/17/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $15.96 General
Category: Inflammation/Rare Disease
10/04/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $26.35 General
Category: Diabetes
10/03/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $22.39 General
Category: UROLOGY
08/09/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $23.96 General
Category: Diabetes
08/02/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.83 General
Category: RESPIRATORY
07/30/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $23.43 General
Category: Diabetes
07/12/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $18.02 General
Category: Biological
07/08/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $12.26 General
Category: Diabetes
06/27/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $23.04 General
Category: Diabetes
06/13/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $15.71 General
Category: NEUROSCIENCE
05/31/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $18.56 General
Category: PAIN
05/10/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $24.80 General
Category: Diabetes
05/07/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $19.80 General
Category: Diabetes
04/19/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $17.46 General
Category: RESPIRATORY
04/02/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $10.10 General
Category: Diabetes
03/29/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $18.59 General
Category: Endocrinology
03/08/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $21.33 General
Category: NEUROSCIENCE
03/05/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $12.77 General
Category: Diabetes
02/27/2024 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $21.08 General
Category: Diabetes
02/23/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $17.16 General
Category: UROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 572 662 $75,605 $52,278
2022 8 626 730 $76,061 $53,029
2021 9 747 964 $102,371 $72,005
2020 11 752 939 $99,123 $58,726
Total Patients
2,697
Total Services
3,295
Medicare Billing
$236,038
Procedure Codes
37

All Medicare Procedures & Services

37 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 217 217 $29,295 $24,525 83.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 95 135 $18,900 $9,482 50.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 102 151 $14,647 $7,312 49.9%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 50 50 $4,023 $3,563 88.6%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 11 11 $3,850 $3,112 80.8%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 16 16 $2,640 $2,325 88.1%
G0008 Administration of influenza virus vaccine Office 2023 56 56 $1,680 $1,590 94.6%
G0009 Administration of pneumococcal vaccine Office 2023 11 11 $330.00 $317.90 96.3%
81002 Urinalysis, manual test Office 2023 14 15 $240.00 $51.15 21.3%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 204 204 $27,540 $24,775 90.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 150 220 $21,340 $10,685 50.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 101 129 $18,060 $9,330 51.7%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2022 56 56 $4,193 $3,860 92.1%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2022 16 16 $2,640 $2,554 96.7%
G0008 Administration of influenza virus vaccine Office 2022 59 59 $1,466 $1,437 98.0%
G0009 Administration of pneumococcal vaccine Office 2022 12 12 $278.00 $273.12 98.2%
81002 Urinalysis, manual test Office 2022 28 34 $544.00 $114.65 21.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 212 212 $28,620 $26,708 93.3%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 214 362 $35,114 $20,235 57.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 135 191 $26,740 $14,939 55.9%
90694 Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage Office 2021 55 55 $3,464 $3,388 97.8%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2021 20 20 $3,300 $3,240 98.2%
99496 Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge Office 2021 12 12 $2,820 $2,112 74.9%
G0008 Administration of influenza virus vaccine Office 2021 60 60 $810.00 $806.30 99.5%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 11 11 $847.00 $436.92 51.6%

About Dr. Kelli Dumm, MD

Dr. Kelli Dumm, MD is a Internal Medicine healthcare provider based in Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760461164.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kelli Dumm, MD has received a total of $3,102 in payments from pharmaceutical and medical device companies, with $564.34 received in 2024. These payments were reported across 190 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,057).

As a Medicare-enrolled provider, Dumm has provided services to 2,697 Medicare beneficiaries, totaling 3,295 services with total Medicare billing of $236,038. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Charleston, WV
  • Active Since 01/13/2006
  • Last Updated 08/07/2013
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1760461164

Products in Payments

  • Ozempic (Drug) $548.60
  • Rybelsus (Drug) $186.71
  • ELIQUIS (Drug) $161.54
  • UBRELVY (Drug) $135.08
  • QULIPTA (Drug) $117.36
  • NURTEC ODT (Drug) $114.16
  • Victoza (Drug) $90.27
  • FARXIGA (Drug) $89.92
  • TRINTELLIX (Drug) $89.43
  • GEMTESA (Drug) $86.80
  • TRELEGY ELLIPTA (Drug) $81.29
  • XARELTO (Drug) $80.21
  • MOUNJARO (Drug) $65.36
  • CHANTIX (Drug) $61.52
  • JANUVIA (Drug) $60.83
  • TRULICITY (Drug) $58.46
  • Trulance (Drug) $56.88
  • TROKENDI XR (Drug) $56.68
  • Trintellix (Drug) $55.15
  • EMGALITY (Drug) $52.46

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Charleston